The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis
- 24 January 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 53 (5), 609-616
- https://doi.org/10.1038/s41409-017-0084-2
Abstract
The Japan Marrow Donor Program (JMDP), established in 1991, has continued to grow in its capacity to facilitate unrelated bone marrow (BMT) and peripheral blood stem cell transplantation (PBSCT) for the past 25 years in Japan. The current donor pool is 463,465 (as of 31 December 2016) and 20,237 transplants were performed with the help of the Japanese Red Cross, government, and supporters. As JMDP introduced PBSCT in 2010, the vast majority of transplants are BMT. All donors are fully typed for HLA-A, B, C, and DR. The peak age of registered donors is around 40 years. The 8/8 HLA-matched donors are found in our registry for 96% of the patients and 54% of the patients receive a transplant. The median time between the initiation of donor search and the transplantation is approximately 122 days. The median interval between the initiation of donor search and identification of the first potential donor is 40 days. The most common diseases for which unrelated BMT/PBSCT is indicated are acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndrome (MDS), and malignant lymphoma. In recent years we have seen a marked increase in elderly patients who received BMT.Keywords
This publication has 9 references indexed in Scilit:
- Study of twice marrow donations from unrelated donors in Japan Marrow Donor ProgramJournal of Hematopoietic Cell Transplantation, 2017
- Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyBone Marrow Transplantation, 2016
- Biological significance of HLA locus matching in unrelated donor bone marrow transplantationBlood, 2015
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. RegistryNew England Journal of Medicine, 2014
- Severe events in donors after allogeneic hematopoietic stem cell donationHaematologica, 2009
- The National Marrow Donor Program 20 Years of Unrelated Donor Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2008
- Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor ProgramTransplantation and Cellular Therapy, 2008
- The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantationBone Marrow Transplantation, 2008
- Effect of Matching of Class I HLA Alleles on Clinical Outcome after Transplantation of Hematopoietic Stem Cells from an Unrelated DonorNew England Journal of Medicine, 1998